Physician profile
Benjamin J Levinson
NPI 1346208865
$12,221.61
in general payments reported to CMS, 2019-2025
61 companies · $1,995 in 2025
The $1,995 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $1,428 · 2021: $1,949 · 2022: $2,116 · 2023: $1,489 · 2024: $1,902 · 2025: $1,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,272 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,272.18 |
| Education | $113.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,537.69 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,438.39 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $839.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $646.98 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $546.45 | 2022-2025 | Rexulti |
| Amarin Pharma, INC. | $527.83 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $498.49 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $486.97 | 2019-2024 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $454.35 | 2019-2025 | Xifaxan |
| Amgen INC. | $426.01 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.91 | 2019-2025 | Jardiance |
| Abbott Laboratories | $413.60 | 2021-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $393.91 | 2020-2025 | |
| Astellas Pharma US INC | $363.65 | 2019-2025 | Veozah, Myrbetriq |
| Sanofi-Aventis U.S. LLC | $356.28 | 2019-2022 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $262.49 | 2024-2025 | Korlym |
| Allergan, INC. | $206.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $177.04 | 2019-2024 | Dificid |
| Axsome Therapeutics, INC. | $149.40 | 2022-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $140.09 | 2019-2022 | |
| Medtronic, INC. | $118.69 | 2024-2025 | Intellis Adaptivestim |
| Arbor Pharmaceuticals, INC. | $118.23 | 2019-2021 | |
| Boston Scientific Corporation | $117.95 | 2022-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Jazz Pharmaceuticals INC. | $116.59 | 2020-2022 | |
| Exact Sciences Corporation | $111.80 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $103.11 | 2022 | |
| Noven Therapeutics, LLC | $91.79 | 2024 | Xelstrym |
| Pfizer INC. | $85.37 | 2019-2024 | |
| Esperion Therapeutics, INC. | $79.16 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $67.07 | 2021 | |
| Upsher-Smith Laboratories LLC | $66.06 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $62.22 | 2020-2021 | |
| Inari Medical, INC. | $62.21 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $55.01 | 2022-2023 | Arexvy, Shingrix |
| Teva Pharmaceuticals USA, INC. | $54.82 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $51.33 | 2024-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $48.41 | 2024-2025 | Voquezna |
| Edwards Lifesciences Corporation | $44.77 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Eisai INC. | $44.45 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $39.23 | 2020 | |
| Lundbeck LLC | $36.04 | 2024-2025 | Rexulti |
| Mannkind Corporation | $35.70 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $32.84 | 2020 | |
| Antares Pharma, INC. | $27.95 | 2020-2025 | Xyosted |
| Recordati_rare_diseases_inc. | $26.54 | 2025 | Isturisa |
| Stryker Corporation | $21.93 | 2025 | Clottriever Bold Catheter |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Aytu Biopharma, INC. | $20.09 | 2019 | |
| Dexcom, INC. | $18.72 | 2021 | |
| Intra-Sana Laboratories | $15.85 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Adlon Therapeutics L.P. | $15.74 | 2021 | |
| Aclaris Therapeutics, INC. | $15.69 | 2019 | |
| Teleflex LLC | $15.25 | 2024 | Urolift |
| Ironwood Pharmaceuticals, INC | $14.59 | 2019 | |
| Bausch Health US, LLC | $14.52 | 2022 | |
| Cvrx, INC. | $13.45 | 2024 | Barostim Neo System |
| Insmed, INC. | $12.72 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.46 | 2021 | |
| Intersect Ent, INC. | $11.79 | 2019 | |
| Genentech USA, INC. | $11.69 | 2020 | |
| Prugen, INC. Pharmaceuticals | $5.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Levinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.